Ahmedabad-based manufacturer and trader of pharmaceutical products, now also offering laboratory testing services.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 2 | 2 | 2 | 4 | 11 | 44 | 44 | 44 |
| Reserves | 14 | 14 | 15 | 21 | 47 | 19 | 22 | 46 |
| Borrowings | 8 | 10 | 3 | 5 | 3 | 4 | 4 | 5 |
| Other Liabilities | 10 | 10 | 15 | 45 | 17 | 20 | 18 | 23 |
| Total Liabilities | 34 | 36 | 35 | 75 | 78 | 87 | 87 | 117 |
| AssetsFixed Assets | 17 | 18 | 18 | 20 | 20 | 19 | 19 | 22 |
| CWIP | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 14 | 16 | 16 | 53 | 56 | 65 | 66 | 84 |
| Total Assets | 34 | 36 | 35 | 75 | 78 | 87 | 87 | 117 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 0 | 1 | 1 | 8 | 3 | -5 | 8 | 4 |
| Cash from Investing | -2 | -3 | -2 | -2 | -4 | -1 | -1 | -14 |
| Cash from Financing | 2 | 2 | 2 | -7 | 5 | 12 | -5 | 4 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -2 | -2 | -1 | 6 | -1 | -7 | 5 | -12 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
524632 · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.